TUBE CITY, LLC – Trademark Portfolio
Entity Type: 16
TUBE CITY, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 6 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GENBLEND and SCRAP OPTIMISER. The owner is based in GLASSPORT, PA.
12 MONONGAHELA AVENUE
GLASSPORT, PA 15045
Showing of trademarks Trademarks
Trademark Classifications
TUBE CITY, LLC's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does TUBE CITY, LLC have?
TUBE CITY, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 cancelled.
What trademark classes does TUBE CITY, LLC file in?
TUBE CITY, LLC files trademarks across 6 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 35 (Advertising & Business), Class 37 (Building & Construction). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are TUBE CITY, LLC's most well-known trademarks?
TUBE CITY, LLC's registered trademark portfolio includes well-known marks such as GENBLEND and SCRAP OPTIMISER. These are among 3 currently registered trademarks in the portfolio.
What is TUBE CITY, LLC's trademark registration success rate?
TUBE CITY, LLC has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.